OUTCOMES FOLLOWING USE OF SUBCUTANEOUS C1-INHIBITOR DURING PREGNANCY IN PATIENTS WITH HEREDITARY ANGIOEDEMA

Levy D.; Banerji A.; Cicardi M.; Feuersenger H.; Chiao J.; Pragst I.; Jacobs I.

首页> 外文期刊>Annals of allergy, asthma, and immunology >OUTCOMES FOLLOWING USE OF SUBCUTANEOUS C1-INHIBITOR DURING PREGNANCY IN PATIENTS WITH HEREDITARY ANGIOEDEMA

【24h】

OUTCOMES FOLLOWING USE OF SUBCUTANEOUS C1-INHIBITOR DURING PREGNANCY IN PATIENTS WITH HEREDITARY ANGIOEDEMA

机译：在遗传性血统患者怀孕期间使用皮下C1抑制剂后果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of allergy, asthma, and immunology》 |2018年第1期|共1页
作者
Levy D.; Banerji A.; Cicardi M.; Feuersenger H.; Chiao J.; Pragst I.; Jacobs I.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. OUTCOMES FOLLOWING USE OF SUBCUTANEOUS C1-INHIBITOR DURING PREGNANCY IN PATIENTS WITH HEREDITARY ANGIOEDEMA [J] . Levy D., Banerji A., Cicardi M., Annals of allergy, asthma, and immunology . 2018,第5Suppla1期

机译：在遗传性血统患者怀孕期间使用皮下C1抑制剂后果
2. C1-INHIBITOR FUNCTION AS A MARKER FOR HEREDITARY ANGIOEDEMA ACTIVITY IN PATIENTS ON SUBCUTANEOUS C1-INHIBITOR [J] . Levy D., Riedl M., Craig T. Annals of allergy, asthma, and immunology . 2019,第5Suppla1期

机译：C1-抑制剂作为皮下C1抑制剂患者遗传性血管内可活动的标志物
3. Successful pregnancy outcome after treatment with C1-inhibitor concentrate in a patient with hereditary angioedema and a history of four miscarriages [J] . FarkasH., CsukaD., TóthF., European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal . 2012,第2期

机译：有遗传性血管性水肿且有四次流产史的患者，使用C1抑制剂治疗后成功怀孕
4. Outcome of second pregnancies when the first pregnancies were supported by metformin in patients of PCOS [C] . Sonia Malik, Kavita Katoch, Gautam Allahbadia World Congress on Fertility and Sterility . 2004

机译：在PCOS患者的二甲双胍支持时，第二次妊娠的结果
5. Screening of natural products for their effect on kallikrein-kinin system: Potential implications in the treatment of hereditary angioedema. [D] . Madkhali, Hassan Abdu. 2015

机译：筛选天然产物对激肽释放酶激肽系统的影响：遗传性血管性水肿治疗的潜在影响。
6. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study [O] . William R. Lumry, Bruce Zuraw, Marco Cicardi, 2021

机译：对皮下C1抑制剂替代疗法治疗的患者的长期健康相关生活质量用于预防遗传性血统的攻击：来自紧凑的开放标签推广研究的结果
7. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study [O] . William R. Lumry, Bruce Zuraw, Marco Cicardi, 2021

机译：对皮下C1抑制剂替代疗法治疗的患者的长期健康相关生活质量，用于预防遗传性血统的攻击：来自紧凑的开放标签推广研究的结果

OUTCOMES FOLLOWING USE OF SUBCUTANEOUS C1-INHIBITOR DURING PREGNANCY IN PATIENTS WITH HEREDITARY ANGIOEDEMA

著录项

相似文献

相关主题

期刊订阅